JF
TNYA icon

Jump Financial’s Tenaya Therapeutics TNYA Stock Holding History

Jump Financial’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,590
Closed -$6.47K – 2223
2025
Q2 		$6.47K Buy
+10,590
New +$5.39K ﹤0.01% 1739
2024
Q3 		– Sell
-21,749
Closed -$67.4K – 2122
2024
Q2 		$67.4K Buy
+21,749
New +$89.8K ﹤0.01% 1670
2023
Q4 		– Sell
-14,600
Closed -$37.2K – 2248
2023
Q3 		$37.2K Sell
14,600
-7,700
-35% -$32.2K ﹤0.01% 1763
2023
Q2 		$131K Buy
+22,300
New +$130K ﹤0.01% 1608
2022
Q4 		– Sell
-20,800
Closed -$60K – 2020
2022
Q3 		$60K Buy
+20,800
New +$97.1K ﹤0.01% 1491

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Jump Financial's TNYA Position: Q3 2025 in Review

Jump Financial sold out of Tenaya Therapeutics (TNYA) in Q3 2025, closing a stake of 10,590 shares — an estimated $6.47K sold.

Jump Financial first reported a position in TNYA in Q3 2022 and held it in 5 quarters. The position peaked at $131K in Q2 2023. 91 funds tracked by Wall St. Rank hold TNYA as of Q3 2025.

  • Jump Financial reported no remaining Tenaya Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 10,590 Tenaya Therapeutics shares in Q3 2025, an estimated $6.47K.
  • Jump Financial first reported a position in Tenaya Therapeutics in Q3 2022 and held it in 5 quarters.
  • Jump Financial's Tenaya Therapeutics position peaked at $131K in Q2 2023.
  • 91 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.